HyperRHO S/D Mini-Dose Interactions
There are 101 drugs known to interact with HyperRHO S/D Mini-Dose (rho (d) immune globulin), along with 4 disease interactions. Of the total drug interactions, 84 are major, and 17 are moderate.
- View all 101 medications that may interact with HyperRHO S/D Mini-Dose
- View HyperRHO S/D Mini-Dose disease interactions (4)
Most frequently checked interactions
View interaction reports for HyperRHO S/D Mini-Dose (rho (d) immune globulin) and the medicines listed below.
- Adriamycin (doxorubicin)
- Alphanate (antihemophilic factor/von willebrand factor)
- Banzel (rufinamide)
- BayGam (immune globulin intramuscular)
- bleomycin
- Cafergot (caffeine / ergotamine)
- ceftriaxone
- chloramphenicol
- Clozaril (clozapine)
- Complera (emtricitabine / rilpivirine / tenofovir disoproxil)
- Corlanor (ivabradine)
- Coumadin (warfarin)
- cyclophosphamide
- Decadron (dexamethasone)
- digoxin immune fab
- Erelzi (etanercept)
- Etopophos (etoposide)
- Fortovase (saquinavir)
- fosinopril
- GastroMARK (ferumoxsil)
- Gengraf (cyclosporine)
- Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide)
- hydroxychloroquine
- Hyperhep (hepatitis b immune globulin)
- Imlygic (talimogene laherparepvec)
- Imuran (azathioprine)
- Kadcyla (ado-trastuzumab emtansine)
- Koate-HP (antihemophilic factor)
- Kyprolis (carfilzomib)
- Lanoxin (digoxin)
HyperRHO S/D Mini-Dose disease interactions
There are 4 disease interactions with HyperRHO S/D Mini-Dose (rho (d) immune globulin) which include:
Report options
QR code containing a link to this page
More about HyperRHO S/D Mini-Dose (rho (d) immune globulin)
- HyperRHO S/D Mini-Dose consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: immune globulins
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.